Total planned funding: $120,666,040
Allocations
Countries/Regions
Ukraine | $120,666,040 |
Organizational Types
Private Contractor | $32,340,981 |
NGO | $28,215,514 |
Unknown | $22,455,060 |
Own Agency | $15,443,371 |
Multi-lateral Agency | $11,275,607 |
University | $5,110,000 |
Other USG Agency | $3,225,507 |
Implementing Agency | $2,600,000 |
Program Areas
Governance and Systems | $50,572,319 |
Treatment | $24,676,485 |
Prevention | $14,324,484 |
Testing | $11,252,687 |
Management and Operations | $10,043,469 |
Care | $9,383,896 |
Budget Codes
OHSS: Health Systems Strengthening | $25,678,263 |
HVSI: Strategic Information | $16,474,516 |
HTXS: Treatment: Adult Treatment | $13,271,195 |
HTXD: Treatment: ARV Drugs | $11,405,290 |
HVCT: Testing: HIV Testing and Counseling | $11,252,687 |
HVMS: Management and Operations | $10,043,469 |
HLAB: Laboratory Infrastructure | $8,419,540 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $7,125,105 |
HVTB: Care: TB/HIV | $6,073,990 |
HVOP: Sexual Prevention: Other Sexual Prevention | $5,298,756 |
HBHC: Care: Adult Care and Support | $1,817,824 |
HMBL: Biomedical Prevention: Blood Safety | $1,774,627 |
HKID: Care: Orphans and Vulnerable Children | $1,492,082 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $125,996 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $0 |
Top Partner Programs
Not Available:
$23,159,776
Countries/Regions
Chemonics International:
$17,819,470
Countries/Regions
USG Aggregated Agencies:
$12,593,784
Countries/Regions
Deloitte Consulting Limited:
$10,671,511
Countries/Regions